Patents
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
04/2009
04/23/2009US20090105289 11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds
04/23/2009US20090105248 3-monosubstituted tropane derivatives as nociceptin receptor ligands
04/23/2009US20090105168 Use Of HDAC And/Or DNMT Inhibitors For Treatment Of Ischemic Injury
04/22/2009EP2050452A1 indenoisoquinolines as topoisomerase inhibitors I useful as antineoplastic agents
04/22/2009EP2049494A2 Tyrosine kinase inhibitors
04/22/2009EP1795527B1 Carbamoyl-substituted spiro derivative
04/22/2009EP1673354B1 Arylindenopyridines and arylindenopyrimidines and their use as adenosine a2a receptor antagonists
04/22/2009CN101415684A Improved process for making apomorphine and apocodeine
04/22/2009CN101415423A Spirocyclic heterocyclic derivatives and methods of their use
04/22/2009CN100481571C Luminescent element material and luminescent element comprising the same
04/16/2009WO2006138589A3 Opioid receptor ligands
04/16/2009WO2006012640A3 Method of administration of dopamine receptor agonists
04/16/2009US20090099362 via by Hofmann rearrangement; intermediate to synthesize gabapentin, an antiepileptic agent; readily available starting materials with simple preparation, lower production cost, and higher product purity; pharmaceutical synthesis
04/15/2009EP2046753A2 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
04/15/2009EP1794165B1 Preparation of opiate analgesics by reductive alkylation
04/15/2009EP1458677B1 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha
04/15/2009CN101410375A Method for producing aromatic compound
04/14/2009US7517994 Heterocyclic inhibitors of MEK and methods of use thereof
04/14/2009US7517517 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
04/14/2009CA2359440C Phenylphenanthridines with pde-iv inhibiting activity
04/09/2009WO2007123732A3 Antifungal and antiparasitic indoloquinoline derivatives
04/09/2009WO2005124453A3 Perylene charge-transport materials, methods of fabrication thereof, and methods of use thereof
04/09/2009US20090093062 Fluorescent Dye Compounds, Conjugates and Uses Thereof
04/09/2009US20090092854 Complexes with tridentate ligands
04/09/2009US20090089939 Indole-derived styryl dye comprising an alkylene linker, a dye composition comprising this dye, and a process for lightening keratin materials using this dye
04/08/2009EP2044937A1 ANALGESIC 5, 9 - METHANOCYCLOOCTA (b) PYRIDIN - 2 (1H) - ONE DERIVATIVES, THEIR PREPARATION METHOD AND USE
04/08/2009EP2044035A1 Process for the covalent coupling of two molecules by means of a diels-alder reaction with inverse electron requirement
04/08/2009EP2044029A1 Tartrate salt of (7s)-7-[(5-fluoro-2-methyl-benzyl)oxy]-2-[(2r)-2-methylpiperazin-1-yl]-6,7-dihydro-5h-cyclopenta[b]pyridine
04/08/2009EP2043444A1 Chemical compounds
04/08/2009EP1448566B3 Chemokine receptor antagonists and methods of use thereof
04/08/2009CN101402636A Propellane compounds, preparation method and application thereof
04/08/2009CN100475822C Synthesis method for producing ecteinascidin compound
04/08/2009CN100475813C 4-oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor
04/07/2009US7514431 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity
04/07/2009CA2300071C Novel compounds for generating chemiluminescence with a peroxidase
04/01/2009EP2042480A1 Aminoindan derivative or salt thereof
04/01/2009EP2040706A2 Modulators of muscarinic receptors
04/01/2009CN101400656A Piperazine derivatives as farnesyl protein transferase inhibitors
03/2009
03/26/2009WO2009038958A1 Facile 'one pot' process for apomorphine from codeine
03/26/2009WO2005067580A3 Naphthofluorescein-based metal sensors, and methods of making and using the same
03/26/2009US20090082389 Pesticidal substituted piperidines
03/26/2009US20090082385 Deuterium-enriched desloratidine
03/26/2009US20090082384 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
03/26/2009US20090082381 Percutaneously Absorbable Ophthalmic Preparation
03/25/2009EP2038258A1 5-urea substituted naphthalimide derivatives, methods of production and pharmaceutical compositions for treating cancer
03/25/2009EP2038241A1 Electroluminescent polymers and use thereof
03/25/2009EP1756063A4 Amido compounds and their use as pharmaceuticals
03/24/2009US7507744 Spiroazabicyclic heterocyclic compounds
03/24/2009US7507732 6,7-Dihydro-5H-cyclopenta[b]pyridine and 5,6,7,8-tetrahydroquinoline compounds; 5-HT2c receptor agonists; to treat diseases like obesity, depression, atypical depression, anxiety, epilepsy, lower urinary tract dysfunction; less toxic; selectivity
03/19/2009WO2009034216A1 Use of oxoisoaporphines and the derivatives thereof as selective inhibitors of monoamino oxidase a
03/19/2009US20090076062 Organic Compounds
03/19/2009US20090076058 Deuterium-enriched finasteride
03/19/2009US20090076057 Deuterium-enriched dutasteride
03/19/2009US20090074825 Colorants based n-halamines compositions and method of making and using
03/18/2009EP1458720B1 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors
03/18/2009EP1456176B1 Improved compounds for generating chemiluminescence with a peroxidase
03/18/2009EP1231877A4 Transdermal administration of huperzine
03/18/2009EP0963984B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
03/18/2009CN101389608A 5-HT7 receptor antagonists
03/17/2009US7504512 BCL-X1 protein inhibitors; anticarcinogenic agents
03/17/2009US7504507 carboxamide linked compounds based on benzo[b][1,6]naphthyridin-1 (2H)-one, which differ from previous acridine based compounds by the incorporation of a lactam or thiolactam function in one of the outer rings
03/12/2009US20090069564 Methods and Compositions for Selectin Inhibition
03/12/2009US20090069368 Fgf-receptor agonist dimeric compounds
03/12/2009US20090069294 Organic Compounds
03/12/2009US20090069282 Alkyne compounds with mch antagonistic activity and medicaments comprising these compounds
03/12/2009US20090068751 Methods of Labelling Polynucleotides with Dibenzorhodamine Dyes
03/11/2009EP2033645A1 Isoquinoline derivatives and methods of use thereof
03/11/2009EP2033644A1 Spiroindene and spiroindane compounds
03/11/2009EP1687278B1 Use of 4-cyano-naphthalene-1, 8-dicarboximide derivatives and related compounds to protect organic material from the damaging effects of light
03/10/2009US7501515 Purified compound exhibits a melting endotherm with a peak temperature of about 262 degrees C. and an exotherm at about 253 degrees C.; solvent purification; useful in treating acne, female hirsutism and particularly benign prostatic hyperplasia
03/10/2009US7501433 Opioid and opioid-like compounds and uses thereof
03/10/2009US7501432 Spiro-piperidine derivatives
03/10/2009US7501425 e.g. 1-Methyl-7-[4-(pyrazol-1-yl)phenylamino]pyrimido[4,5-d]pyrimidin-2(1H)-one; anticarcinogenic agents; restenosis, angiogenesis and atherosclerosis
03/05/2009WO2009028563A1 Process for production of cis-3-substituted-3- azabicyclo[3.2.1]octan-8-ol derivative
03/05/2009WO2009027952A1 Benzoterrylene derivatives
03/05/2009WO2009027295A1 3-azabicyclo (4.1.0) heptane derivatives useful as norepinephrine, serotonin or dopamine reuptake inhibitors
03/05/2009WO2009027294A1 Substituted azabicyclo [4.1.0] heptane compounds for use as monoamine reuptake inhibitors
03/05/2009WO2009026935A1 Catecholamine derivatives and prodrugs thereof
03/05/2009WO2008055068A3 Inhibitors of histone deacetylase
03/05/2009WO2008010073A8 Tartrate salt of (7s)-7-[(5-fluoro-2-methyl-benzyl)oxy]-2-[(2r)-2-methylpiperazin-1-yl]-6,7-dihydro-5h-cyclopenta[b]pyridine
03/05/2009US20090062546 Dolasetron trifluoroacetate, polymorphs of dolasetron trifluoroacetate and process for preparation thereof
03/05/2009US20090062543 Uv excitable fluorescent energy transfer dyes
03/05/2009US20090062335 Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
03/05/2009US20090062334 Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
03/05/2009US20090062329 Bisnaphthalimidopropyl derivative compounds with anti-parasite and anti-cancer activity
03/05/2009US20090062324 Catecholamine derivatives and prodrugs thereof
03/05/2009US20090062322 Novel Tricyclic Spiropiperidines or Spiropyrrolidines
03/05/2009US20090062268 Novel inhibitors of poly(adp-ribose)polymerase (parp)
03/05/2009CA2697688A1 Catecholamine derivatives and prodrugs thereof
03/04/2009EP2029611A2 17-desmethylrapamycin and analogues thereof, methods for their production and their use as immunosupressants, anticancer agents, antifungal agents etc.
03/04/2009EP2029545A2 Bisnaphthalimidopropyl derivative compounds with anti-parasite and anti-cancer activity
03/04/2009EP1123099B1 Novel indenoisoquinolines as antineoplastic agents
03/04/2009CN101379038A Fluorescent brighteners, methods of preparation thereof, fluorescent brightener compositions, and methods of preparation and uses thereof
03/04/2009CN100465177C An oxygen, nitrogen heterocyclic naphthoyl imine kind compound and a biological application thereof
03/03/2009US7498323 Spiro-piperidine compounds and medicinal use thereof
02/2009
02/26/2009US20090054649 Bridged Organosilane and Production Method Thereof
02/26/2009US20090054429 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
02/26/2009US20090054396 Substituted thiophenes and uses thereof
02/25/2009CN101372473A Preparation of N-hydroxy diimide
02/24/2009US7495100 Anticancer agents; topoisomerase inhibitors
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 110